Achieving National HIV/AIDS Strategy targets would save lives, be cost effective

September 28, 2017

An analysis led by a team of Massachusetts General Hospital (MGH) investigators shows that achieving the treatment targets of the National HIV/AIDS Strategy (NHAS) by 2020 not only would prevent hundreds of thousands of new infections and deaths but also would demonstrate excellent value. Their study published in the Journal of Infectious Diseases, finds that meeting the NHAS goals - 90 percent of HIV infected individuals know their diagnosis, 80 percent of whom achieve virologic suppression through antiretroviral drug treatment (ART) - would save more than two million years of life over the next 20 years.

"If nearly everyone with HIV in the U.S. were in care, on medication and virally suppressed, we would stop the epidemic in its tracks," says Rochelle P. Walensky, MD, MPH, chief of the MGH Division of Infectious Diseases and senior author of the report. "Achieving the NHAS goals would bring us one step closer to that goal."

Released by the White House in 2015, the NHAS was designed to bring U.S. HIV/AIDS policies in line with those of the Joint United Nations Programme on HIV/AIDS - which calls for diagnosing 90 percent of HIV-infected persons worldwide, linking 90 percent of identified cases to ART, and achieving virologic suppression among 90 percent of ART recipients. Achieving the NHAS targets would achieve successful virologic suppression in 72 percent of infected individuals, compared with current estimates of 49 percent.

The current study was designed to identify the expected return on investment for the programs required to achieve NHAS goals, as well as highlight the significant toll in terms of illness and deaths if those goals were not achieved. Since NHAS also emphasizes reducing treatment disparities in communities at high risk for HIV infection, the MGH-led team conducted a separate analysis on the impact of NHAS among black men who have sex with men (MSM), the group with the highest risk of contracting HIV.

Using a mathematical model for assessing the of preventing HIV/AIDS, the investigators compared the forecasted results of continuing the current pace of HIV diagnosis, linkage to and retention in treatment, and viral suppression to those of achieving NHAS goals - projecting both clinical benefits and costs over a 20-year period. While continuing at the current pace would result in 750,000 deaths from HIV/AIDS over 20 years; achieving NHAS would reduce total deaths to 551,000, preventing almost 200,000 deaths. Among black MSM, NHAS would cut the number of deaths from 110,000 to 65,000.

While meeting NHAS targets would cost $645.7 billion over the next 20 years, compared with $525.3 billion under the current pace, the number of lives saved would lead to a cost effectiveness ratio of $68,900 per quality-adjusted life year (QALY) - well within the U.S. cost-effectiveness standard of $100,000/QALY. Among the black MSM population, achieving the NHAS strategy demonstrated even greater value, with a ratio of $38,300/QALY. The investigators note that since almost 75 percent of costs are attributable to ART, reducing the price of ART drugs could lead to even greater cost effectiveness.

"Achieving NHAS won't be cheap, but it would be affordable and cost effective," says co-author Kenneth Freedberg, MD, MSc, MGH Infectious Diseases. "It would make good public health and economic sense to first focus NHAS implementation on black MSM, since they are at considerably higher risk than the general population. Overall, fully implementing NHAS could avert more than 200,000 deaths and prevent more than 250,000 HIV infections over the next 20 years."

Walensky adds, "Achieving NHAS goals is entirely feasible. One of the biggest barriers is retaining patients in care, but our projections demonstrate that increasing two-year retention rates from 78 percent to 89 percent would be enough to reach these goals. This study is only the latest contribution to the large evidence base demonstrating conclusively that we have it in our clinical and economic power to bring the HIV/AIDS epidemic in the U.S. to a halt. Now is the time to do so."

Explore further: A path toward ending AIDS in the US by 2025

More information: The Journal of Infectious Diseases (2017). DOI: 10.1093/infdis/jix349

Related Stories

A path toward ending AIDS in the US by 2025

May 15, 2017
A new study describes an ambitious but feasible path toward what may have seemed unachievable just a decade ago: an end to the AIDS epidemic in the U.S. Using prevention surveillance data to model rates of HIV incidence, ...

Number of HIV infections falling in United States, but fails to meet reduction goals

May 3, 2016
The number of new HIV infections occurring annually in the United States decreased by an estimated 11 percent from 2010 to 2015, while the HIV transmission rate decreased by an estimated 17 percent during the same time period, ...

New UN treatment targets for HIV/AIDS would be 'expensive but worth every penny'

May 30, 2016
A new study finds that implementing the United Nations targets for HIV testing and treatment would be an expensive but ultimately very cost-effective way to increase survival, reduce the number of children orphaned by HIV, ...

Vaccine, improved treatment are keys to control of a surging HIV pandemic

March 20, 2017
Development and widespread use of a vaccine that's even partially effective against HIV, along with more progress toward diagnosis and treatment, offer the best hopes for turning the corner on a global pandemic that's still ...

Achieving a world without AIDS: Scale must give way to focus, details

January 27, 2015
The global AIDS community has its sights set on three new goals, known as the "90-90-90" targets. That is, by 2020, 90 percent of people living with HIV should know their HIV status, 90 percent of those who test positive ...

HIV care could save lives and billions of dollars, computer model predicts

October 26, 2015
A computer model developed by Johns Hopkins health care delivery specialists predicts that strengthening a handful of efforts to keep people with HIV in lifetime care, along with more rigorous testing, would potentially avert ...

Recommended for you

Study suggests a way to stop HIV in its tracks

December 1, 2017
When HIV-1 infects an immune cell, the virus travels to the nucleus so quickly there's not enough time to set off the cell's alarm system.

Discovery puts the brakes on HIV's ability to infect

November 30, 2017
Viewed with a microscope, the virus faintly resembles a pineapple—the universal symbol of welcome. But HIV, the virus that causes AIDS, is anything but that. It has claimed the lives of more than 35 million people so far.

Rising levels of HIV drug resistance

November 30, 2017
HIV drug resistance is approaching and exceeding 10% in people living with HIV who are about to initiate or reinitiate first-line antiretroviral therapy, according to the largest meta-analysis to date on HIV drug resistance, ...

Male circumcision and antiviral drugs appear to sharply reduce HIV infection rate

November 29, 2017
A steep drop in the local incidence of new HIV infections accompanied the rollout of a U.S.-funded anti-HIV program in a large East-African population, according to a study led by researchers at Johns Hopkins Bloomberg School ...

Combination HIV prevention reduces new infections by 42 percent in Ugandan district

November 29, 2017
A study published today in the New England Journal of Medicine provides real-world evidence that implementing a combination of proven HIV prevention measures across communities can substantially reduce new HIV infections ...

Research on HIV viral load urges updates to WHO therapy guidelines

November 24, 2017
A large cohort study in South Africa has revealed that that low-level viraemia (LLV) in HIV-positive patients who are receiving antiretroviral treatment (ART) is an important risk factor for treatment failure.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.